P-025: Investigating the effect of irreversible proteasome inhibitor carfilzomib in in vivo models of cardiometabolic syndrome and early stage HFrEFP: prophylactic role of metformin
Clinical Lymphoma Myeloma and Leukemia（2022）
关键词
irreversible proteasome inhibitor carfilzomib,irreversible proteasome inhibitor,early stage hfrefp,cardiometabolic syndrome,metformin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要